Concepedia

Kamlesh Bala

KB

3

Publications

100

Citations

3

H-Index

2009

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Kamlesh Bala is an author at Novartis (Switzerland) specializing in drug discovery, pharmacotherapy, and medicine.

ORCID

Top concepts

Publications per year

2009–2021

3

Publications

3

7-Azaindole-3-acetic acid derivatives: Potent and selective CRTh2 receptor antagonists

David A. Sandham, Claire Adcock, Kamlesh Bala et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 43 citations · Full text

, , +4

Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease

Darren Le Grand, Martin Gosling, Urs Baettig et al. · Journal of Medicinal Chemistry · 2021 · 35 citations · Full text

Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases

David A. Sandham, Nicola Arnold, Heinrich Aschauer et al. · Bioorganic & Medicinal Chemistry · 2013 · 22 citations · Full text

, , +8

Rows per page

1–3 of 3